Tubersol Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The tubersol market research report is one of a series of new reports that provides tubersol market statistics, including the tubersol industry global market size, regional shares, competitors with the tubersol market share, detailed tubersol market segments, market trends, and opportunities, and any further data you may need to thrive in the tubersol industry. This tubersol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to rising tuberculosis prevalence, increased focus on latent TB diagnosis, global initiatives to eliminate tuberculosis, growing awareness of tuberculosis testing, and government immunization and screening programs. Major trends in the forecast period include advancements in diagnostic tools, advancements in molecular diagnostic methods, development of new diagnostic standards, ongoing investment in research and development, and advancements such as liquid biopsy techniques.

The increasing prevalence of tuberculosis (TB) is expected to drive the growth of the Tubersol market. TB is a contagious bacterial infection caused by Mycobacterium tuberculosis, which primarily affects the lungs but can also spread to other parts of the body. Factors contributing to the rising prevalence of TB include co-infection with HIV/AIDS, drug resistance, globalization, migration, poor nutrition, overcrowded living conditions, limited healthcare access, stigma, and inadequate ventilation. Tubersol is used in the tuberculin skin test (TST), helping detect latent TB infections by triggering an immune response to the purified protein derivative from the TB bacteria. According to the Centers for Disease Control and Prevention, in November 2023, the U.S. reported 8,331 cases of TB in 2022, representing a 5.9% increase from the previous year. This rise in cases is expected to further drive the demand for Tubersol.

The growth of the Tubersol market is also being fueled by rising government initiatives aimed at tackling tuberculosis. Governments around the world have increased funding, policy support, and collaborative efforts to improve TB diagnosis, treatment, and prevention, which have led to more effective control of the disease and better public health outcomes. These initiatives include enhanced screening programs, increased funding for TB control, and international partnerships, all of which increase the demand for TB testing and diagnostic solutions, such as Tubersol. For example, in October 2024, the World Health Organization reported that $22 billion annually is required for TB prevention, diagnosis, treatment, and care to meet global objectives by 2027, with 80% of this funding expected to come from domestic sources. As governments invest more in TB control, the demand for Tubersol is set to rise.

The development of healthcare infrastructure is another key factor driving the growth of the Tubersol market. Healthcare infrastructure encompasses the facilities, equipment, and systems that support the delivery of medical services, ensuring effective and accessible care. As medical technologies advance and healthcare demands increase, governments have invested more in developing modern healthcare facilities and improving access to healthcare services. This development supports the wider availability of Tubersol, ensures its proper administration, and integrates it more effectively into national TB control programs. For instance, the American Health Care Association reported in May 2023 that the U.S. had 6,129 hospitals, marking a 0.591% increase from the previous year. As healthcare infrastructure continues to grow, it plays a key role in expanding the use of Tubersol and facilitating its distribution, further propelling market growth.

The key company operating in the tubersol market is Sanofi S.A.

North America was the largest region in the tubersol market in 2024. The regions covered in tubersol report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tubersol market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Tubersol is a purified protein derivative (PPD) solution used in the tuberculin skin test (TST) for diagnosing tuberculosis (TB) infection. The solution is injected under the skin, and the resulting reaction at the injection site helps determine whether an individual has been exposed to Mycobacterium tuberculosis.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary clinical indications for Tubersol include tuberculosis screening, diagnosis of active tuberculosis, diagnosis of latent tuberculosis, and other respiratory diseases. Tuberculosis screening involves identifying individuals with latent or active TB infection through methods such as the tuberculin skin test, blood assays, or chest X-rays to enable early diagnosis and treatment. Tubersol is available in both single-dose and multi-dose vial formulations and is distributed through various channels, including hospitals, clinics, retail and specialty pharmacies, and online sales. It serves a range of end users, including adults, geriatrics, and pediatric populations.

The tubersol market consists of sales of syringes and needles, diagnostic reagents, refrigeration storage units, multi-dose vials, and purified protein derivative (PPD) injections. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.